IMNM
Price
$23.62
Change
+$3.66 (+18.34%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
2.67B
46 days until earnings call
Intraday BUY SELL Signals
MAZE
Price
$31.26
Change
+$2.83 (+9.95%)
Updated
Jul 2, 04:59 PM (EDT)
Capitalization
1.73B
45 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMNM vs MAZE

IMNM vs MAZE Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMNM vs. MAZE commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and MAZE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2026
Stock price -- (IMNM: $19.96 vs. MAZE: $28.43)
Brand notoriety: IMNM and MAZE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 266% vs. MAZE: 401%
Market capitalization -- IMNM: $2.67B vs. MAZE: $1.73B
IMNM [@Biotechnology] is valued at $2.67B. MAZE’s [@Biotechnology] market capitalization is $1.73B. The market cap for tickers in the [@Biotechnology] industry ranges from $134.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileMAZE’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • MAZE’s FA Score: 1 green, 4 red.
According to our system of comparison, MAZE is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 4 TA indicator(s) are bullish while MAZE’s TA Score has 5 bullish TA indicator(s).

  • IMNM’s TA Score: 4 bullish, 4 bearish.
  • MAZE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both IMNM and MAZE are a good buy in the short-term.

Price Growth

IMNM (@Biotechnology) experienced а +2.89% price change this week, while MAZE (@Biotechnology) price change was +5.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.30%. For the same industry, the average monthly price growth was +5.93%, and the average quarterly price growth was +1921.84%.

Reported Earning Dates

IMNM is expected to report earnings on Aug 19, 2026.

MAZE is expected to report earnings on Aug 18, 2026.

Industries' Descriptions

@Biotechnology (+2.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($2.67B) has a higher market cap than MAZE($1.73B). IMNM YTD gains are higher at: -7.076 vs. MAZE (-31.378). MAZE has higher annual earnings (EBITDA): -131.29M vs. IMNM (-235.83M). IMNM has more cash in the bank: 583M vs. MAZE (352M). IMNM has less debt than MAZE: IMNM (3.69M) vs MAZE (61.2M). MAZE has higher revenues than IMNM: MAZE (20M) vs IMNM (4.02M).
IMNMMAZEIMNM / MAZE
Capitalization2.67B1.73B155%
EBITDA-235.83M-131.29M180%
Gain YTD-7.076-31.37823%
P/E RatioN/A191.34-
Revenue4.02M20M20%
Total Cash583M352M166%
Total Debt3.69M61.2M6%
TECHNICAL ANALYSIS
Technical Analysis
IMNMMAZE
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
63%
Momentum
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
82%
Bullish Trend 9 days ago
90%
Declines
ODDS (%)
Bearish Trend 19 days ago
86%
Bearish Trend 27 days ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signal:
Gain/Loss:
MAZE
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
INOV36.860.29
+0.78%
Innovator Intl Dev Pwr Bffr ETF - Nov
CRWL54.26N/A
N/A
GraniteShares 2x Long CRWD Daily ETF
LDRX34.55N/A
N/A
SGI Enhanced Market Leaders ETF
RFV142.43-0.31
-0.22%
Invesco S&P MidCap 400® Pure Value ETF
DES40.32-0.32
-0.79%
WisdomTree US SmallCap Dividend ETF

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KURA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
N/A
KURA - IMNM
50%
Loosely correlated
N/A
KYTX - IMNM
46%
Loosely correlated
N/A
RLAY - IMNM
44%
Loosely correlated
N/A
VYGR - IMNM
44%
Loosely correlated
N/A
NRIX - IMNM
43%
Loosely correlated
N/A
More

MAZE and

Correlation & Price change

A.I.dvisor indicates that over the last year, MAZE has been loosely correlated with AVXL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MAZE jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAZE
1D Price
Change %
MAZE100%
N/A
AVXL - MAZE
40%
Loosely correlated
N/A
PROK - MAZE
37%
Loosely correlated
N/A
IMNM - MAZE
33%
Loosely correlated
N/A
ADMA - MAZE
30%
Poorly correlated
N/A
BEAM - MAZE
30%
Poorly correlated
N/A
More